YEAR
- 2018.06.22 What consequence is anticipated by the emergence of novel SPPARMa agent developed so as to achieve an improved safety/efficacy balance? Motonobu Anai, Toshiya Tanaka, Tatsuhiko Kodama.Jpn Pharmacol Ther. 46: 471-480 (2018).
- 2011.12.07 Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. Wang L, Tsutsumi S, Kawaguchi T, Nagasaki K, Tatsuno K, Yamamoto S, Sang F, Sonoda K, Sugawara M, Saiura A, Hirono S, Yamaue H, Miki Y, Isomura M, Totoki Y, Nagae G, Isagawa T, Ueda H, Murayama-Hosokawa S, Shibata T, Sakamoto H, Kanai Y, Kaneda A, Noda T, Aburatani H.Genome Res. 2012 Feb;22(2):208-19. doi: 10.1101/gr.123109.111
- 2016.04.12 Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Fujimoto A, Furuta M, Totoki Y, Tsunoda T, Kato M, Shiraishi Y, Tanaka H, Taniguchi H, Kawakami Y, Ueno M, Gotoh K, Ariizumi S, Wardell CP, Hayami S, Nakamura T, Aikata H, Arihiro K, Boroevich KA, Abe T, Nakano K, Maejima K, Sasaki-Oku A, et al.Nat Genet. 2016 May;48(5):500-9. doi: 10.1038/ng.3547. Epub 2016 Apr 11.
- 2015.04.23 Widespread macromolecular interaction perturbations in human genetic disorders. Sahni N, Yi S, Taipale M, Fuxman Bass JI, Coulombe-Huntington J, Yang F, Peng J, Weile J, Karras GI, Wang Y, Kovács IA, Kamburov A, Krykbaeva I, Lam MH, Tucker G, Khurana V, Sharma A, Liu YY, Yachie N, Zhong Q, Shen Y, Palagi A, San-Miguel A, Fan C, Balcha D, Dricot A, Jordan DM, Walsh JM, Shah AA, Yang X, Stoyanova AK, Leighton A, Calderwood MA, Jacob Y, Cusick ME, Salehi-Ashtiani K, Whitesell LJ, Sunyaev S, Berger B, Barabási AL, Charloteaux B, Hill DE, Hao T, Roth FP, Xia Y, Walhout AJM, Lindquist S, Vidal M.Cell. 2015 Apr 23;161(3):647-660. doi: 10.1016/j.cell.2015.04.013
- 2021.09.25 Wilms' tumor 1-associating protein complex regulates alternative splicing and polyadenylation at potential G-quadruplex-forming splice site sequences. Horiuchi K, Kawamura T, Hamakubo T.J Biol Chem. 2021 11;297(5):101248. doi: 10.1016/j.jbc.2021.101248
- 2006.11.06 Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA. Horiuchi K, Umetani M, Minami T, Okayama H, Takada S, Yamamoto M, Aburatani H, Reid PC, Housman DE, Hamakubo T, Kodama T.Proc. Natl. Acad. Sci. U.S.A. 2006 Nov 14;103(46):17278-83. doi: 10.1073/pnas.0608357103
- 2010.04.09 Wnt signaling and its downstream target N-myc regulate basal progenitors in the developing neocortex. Kuwahara A, Hirabayashi Y, Knoepfler PS, Taketo MM, Sakai J, Kodama T, Gotoh Y.Development. 2010 Apr;137(7):1035-44. doi: 10.1242/dev.046417
- 2007.08.30 Wnt4 is a local repulsive cue that determines synaptic target specificity. Inaki M, Yoshikawa S, Thomas JB, Aburatani H, Nose A.Curr. Biol. 2007 Sep 18;17(18):1574-9. doi: 10.1016/j.cub.2007.08.013
CLOSE